Green Leaf Pharmaceutical (02186) rose 2.96% against the market to 3.82 yuan. The Group announced that with regard to the proposed spin-off and independent listing of Shandong Boan Biotechnology Co., Ltd., the Stock Exchange of Hong Kong has confirmed that the company can carry out the proposed spin-off in accordance with the 15th application guidelines of the listing rules.
【港股通】绿叶制药(02186)逆市高开2.96% 拟分拆博安生物独立上市
[Hong Kong Stock Connect] Luye Pharmaceutical (02186) opened against the market at 2.96% and plans to split Boan Biotech and go public independently
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.